Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Neuregulin-1 Gene and Schizophrenia, and its Negative Symptoms in an Iranian Population

Maryam Hatami 1 , Narges Karamghadiri 1 , Hoorie Mohaghegh 2 , Sadegh Yoosefee 3 , Morteza Karimipoor 4 , Mahmoudreza Hadjighasem 2 , 5 and Esmaeil Shahsavand Ananloo 1 , *
Authors Information
1 Department of Genomic Psychiatry and Behavioral Genomics, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran
4 Pasteur Institute of Iran, Tehran, Iran
5 Brain and Spinal Cord Injury Research Center, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: December 2017, 11 (4); e4484
  • Published Online: October 15, 2016
  • Article Type: Original Article
  • Received: October 23, 2015
  • Revised: May 13, 2016
  • Accepted: September 22, 2016
  • DOI: 10.5812/ijpbs.4484

To Cite: Hatami M, Karamghadiri N, Mohaghegh H, Yoosefee S, Karimipoor M, et al. Neuregulin-1 Gene and Schizophrenia, and its Negative Symptoms in an Iranian Population, Iran J Psychiatry Behav Sci. 2017 ;11(4):e4484. doi: 10.5812/ijpbs.4484.

Abstract
Copyright © 2016, Mazandaran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objective
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. [PubMed: 23993280].
  • 2. Cardno AG, Gottesman ,I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet. 2000;97(1):12-7. [PubMed: 10813800].
  • 3. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60(12):1187-92. doi: 10.1001/archpsyc.60.12.1187. [PubMed: 14662550].
  • 4. International Schizophrenia C, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460(7256):748-52. doi: 10.1038/nature08185. [PubMed: 19571811].
  • 5. Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet. 2003;361(9355):417-9. doi: 10.1016/S0140-6736(03)12379-3. [PubMed: 12573388].
  • 6. Baron M. Genetics of schizophrenia and the new millennium: progress and pitfalls. Am J Hum Genet. 2001;68(2):299-312. doi: 10.1086/318212. [PubMed: 11170887].
  • 7. Goff DC. Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia. World Psychiatry. 2013;12(2):99-107. doi: 10.1002/wps.20026. [PubMed: 23737409].
  • 8. Di Forti M, Iyegbe C, Sallis H, Kolliakou A, Falcone MA, Paparelli A, et al. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry. 2012;72(10):811-6. doi: 10.1016/j.biopsych.2012.06.020. [PubMed: 22831980].
  • 9. Xu C, Aragam N, Li X, Villla EC, Wang L, Briones D, et al. BCL9 and C9orf5 are associated with negative symptoms in schizophrenia: meta-analysis of two genome-wide association studies. PLoS One. 2013;8(1):51674. doi: 10.1371/journal.pone.0051674. [PubMed: 23382809].
  • 10. Cannon TD, Keller MC. Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol. 2006;2:267-90. doi: 10.1146/annurev.clinpsy.2.022305.095232. [PubMed: 17716071].
  • 11. Foussias G, Agid O, Fervaha G, Remington G. Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders. Eur Neuropsychopharmacol. 2014;24(5):693-709. doi: 10.1016/j.euroneuro.2013.10.017. [PubMed: 24275699].
  • 12. Montgomery SA, van Zwieten-Boot B. ECNP consensus meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, March 2004. Eur Neuropsychopharmacol. 2007;17(1):70-7. doi: 10.1016/j.euroneuro.2006.05.004. [PubMed: 16842980].
  • 13. Pinacho R, Villalmanzo N, Roca M, Iniesta R, Monje A, Haro JM, et al. Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms. J Psychiatr Res. 2013;47(7):926-34. doi: 10.1016/j.jpsychires.2013.03.004. [PubMed: 23540600].
  • 14. Manoliu A, Riedl V, Doll A, Bauml JG, Muhlau M, Schwerthoffer D, et al. Insular Dysfunction Reflects Altered Between-Network Connectivity and Severity of Negative Symptoms in Schizophrenia during Psychotic Remission. Front Hum Neurosci. 2013;7:216. doi: 10.3389/fnhum.2013.00216. [PubMed: 23730284].
  • 15. Wang Y, Fang Y, Shen Y, Xu Q. Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia. Psychiatry Res. 2010;179(2):147-50. doi: 10.1016/j.psychres.2009.03.029. [PubMed: 20483479].
  • 16. Chien YL, Hwu HG, Fann CS, Chang CC, Tsuang MT, Liu CM. DRD2 haplotype associated with negative symptoms and sustained attention deficits in Han Chinese with schizophrenia in Taiwan. J Hum Genet. 2013;58(4):229-32. doi: 10.1038/jhg.2012.157. [PubMed: 23364393].
  • 17. Bennett M. Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression. Aust N Z J Psychiatry. 2009;43(8):711-21. doi: 10.1080/00048670903001943. [PubMed: 19629792].
  • 18. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 2002;71(4):877-92. doi: 10.1086/342734. [PubMed: 12145742].
  • 19. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet. 2003;72(1):83-7. [PubMed: 12478479].
  • 20. Thomson PA, Christoforou A, Morris SW, Adie E, Pickard BS, Porteous DJ, et al. Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry. 2007;12(1):94-104. doi: 10.1038/sj.mp.4001889. [PubMed: 16940976].
  • 21. Kukshal P, Bhatia T, Bhagwat AM, Gur RE, Gur RC, Deshpande SN, et al. Association study of neuregulin-1 gene polymorphisms in a North Indian schizophrenia sample. Schizophr Res. 2013;144(1-3):24-30. doi: 10.1016/j.schres.2012.12.017. [PubMed: 23360725].
  • 22. Schizophrenia Psychiatric Genome-Wide Association Study C. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011;43(10):969-76. doi: 10.1038/ng.940. [PubMed: 21926974].
  • 23. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45(10):1150-9. doi: 10.1038/ng.2742. [PubMed: 23974872].
  • 24. Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry. 2012;17(9):887-905. doi: 10.1038/mp.2012.37. [PubMed: 22584867].
  • 25. Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res. 2003;284(1):14-30. [PubMed: 12648463].
  • 26. Walker RM, Christoforou A, Thomson PA, McGhee KA, Maclean A, Muhleisen TW, et al. Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder. Neurosci Lett. 2010;478(1):9-13. doi: 10.1016/j.neulet.2010.04.056. [PubMed: 20435087].
  • 27. Shiota S, Tochigi M, Shimada H, Ohashi J, Kasai K, Kato N, et al. Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population. J Hum Genet. 2008;53(10):929-35. doi: 10.1007/s10038-008-0332-9. [PubMed: 18704261].
  • 28. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. [PubMed: 3344216].
  • 29. Mwansisya TE, Wang Z, Tao H, Zhang H, Hu A, Guo S, et al. The diminished interhemispheric connectivity correlates with negative symptoms and cognitive impairment in first-episode schizophrenia. Schizophr Res. 2013;150(1):144-50. doi: 10.1016/j.schres.2013.07.018. [PubMed: 23920057].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments